ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,174 | -1.0% | 20,982 | 0.0% | 0.00% | – |
Q2 2023 | $42,593 | +2.0% | 20,982 | 0.0% | 0.00% | – |
Q1 2023 | $41,754 | +0.6% | 20,982 | +19.8% | 0.00% | – |
Q4 2022 | $41,515 | +15.3% | 17,517 | 0.0% | 0.00% | – |
Q3 2022 | $36,000 | -18.2% | 17,517 | 0.0% | 0.00% | – |
Q2 2022 | $44,000 | +10.0% | 17,517 | 0.0% | 0.00% | – |
Q1 2022 | $40,000 | +5.3% | 17,517 | 0.0% | 0.00% | – |
Q4 2021 | $38,000 | -26.9% | 17,517 | 0.0% | 0.00% | – |
Q3 2021 | $52,000 | -14.8% | 17,517 | 0.0% | 0.00% | – |
Q2 2021 | $61,000 | -4.7% | 17,517 | 0.0% | 0.00% | – |
Q1 2021 | $64,000 | -8.6% | 17,517 | -0.0% | 0.00% | – |
Q4 2020 | $70,000 | – | 17,525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Standard LLC | 1,174,270 | $2,360,283 | 2.13% |
BML Capital Management, LLC | 706,930 | $1,420,929 | 1.30% |
Newtyn Management, LLC | 300,000 | $603,000 | 0.15% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $94,365 | 0.00% |
OSAIC HOLDINGS, INC. | 55 | $110 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 42,514 | $85,453 | 0.00% |
Parallel Advisors, LLC | 244 | $490 | 0.00% |
BANK OF AMERICA CORP /DE/ | 31 | $62 | 0.00% |
WELLS FARGO & COMPANY/MN | 75 | $151 | 0.00% |
NORTHERN TRUST CORP | 20,982 | $42,174 | 0.00% |